» Articles » PMID: 25483619

Regulation of Dopamine D2 Receptor-mediated Extracellular Signal-regulated Kinase Signaling and Spine Formation by GABAA Receptors in Hippocampal Neurons

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2014 Dec 9
PMID 25483619
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Dopamine (DA) signaling via DA receptors is known to control hippocampal activity that contributes to learning, memory, and synaptic plasticity. In primary hippocampal neuronal culture, we observed that dopamine D2 receptors (D2R) co-localized with certain subtypes of GABAA receptors, namely α1, β3, and γ2 subunits, as revealed by double immunofluorocytochemical analysis. Treatment with the D2R agonist, quinpirole, was shown to elicit an increase in phosphorylation of extracellular signal-regulated kinase (ERK) in hippocampal neurons. This phosphorylation was inhibited by pretreatment with the GABAA receptor agonist, muscimol. Furthermore, treatment of hippocampal neurons with quinpirole increased the dendritic spine density and this regulation was totally blocked by pretreatment with a MAP kinase kinase (MEK) inhibitor (PD98059), D2R antagonist (haloperidol), or by the GABAA receptor agonist, muscimol. These results suggest that D2R-mediated ERK phosphorylation can control spine formation and that the GABAA receptor negatively regulates the D2R-induced spine formation through ERK signaling in hippocampal neurons, thus indicating a potential role of D2R in the control of hippocampal neuronal excitability.

Citing Articles

Sex-Related and Brain Regional Differences of URB597 Effects on Modulation of MAPK/PI3K Signaling in Chronically Stressed Rats.

Jankovic M, Spasojevic N, Ferizovic H, Stefanovic B, Virijevic K, Vezmar M Mol Neurobiol. 2023; 61(3):1495-1506.

PMID: 37725215 DOI: 10.1007/s12035-023-03649-5.


Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipine.

Collier T, Begg L, Stancati J, Mercado N, Sellnow R, Sandoval I Exp Neurol. 2023; 369:114522.

PMID: 37640098 PMC: 10591902. DOI: 10.1016/j.expneurol.2023.114522.


Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease.

Kim B, Weerasinghe-Mudiyanselage P, Ang M, Lee J, Kang S, Kim J Int Neurourol J. 2022; 26(Suppl 2):S94-105.

PMID: 36503212 PMC: 9767684. DOI: 10.5213/inj.2244252.126.


Dose-Dependent Biphasic Action of Quetiapine on AMPK Signalling via 5-HT7 Receptor: Exploring Pathophysiology of Clinical and Adverse Effects of Quetiapine.

Okada M, Fukuyama K, Motomura E Int J Mol Sci. 2022; 23(16).

PMID: 36012369 PMC: 9409360. DOI: 10.3390/ijms23169103.


Brexpiprazole Reduces 5-HT7 Receptor Function on Astroglial Transmission Systems.

Fukuyama K, Motomura E, Okada M Int J Mol Sci. 2022; 23(12).

PMID: 35743014 PMC: 9223571. DOI: 10.3390/ijms23126571.